Risk Factors of Noncompliance to Preventive Mass Drug Administration for Eliminating Lymphatic Filariasis: A Case-Control Study in Jawi District, Northwest Ethiopia
Table 3
Multivariable logistic regression analysis results of the factors for noncompliance to preventive MDA using ivermectin-with-albendazole for the elimination of lymphatic filariasis in Northwest Ethiopia (n = 690).
Variables
Cases n = 345
Control n = 345
COR (95% CI)
AOR (95% CI)
Age
<30
206
162
1.67 (1.24–2.26)
1.60 (1.10–2.33)
≥30
139
183
1
Gender
Male
122
170
1
Female
223
175
1.78 (1.42–3.06)
1.56 (1.24–3.93)
Religion
Orthodox
323
325
0.90 (0.48–1.69)
1.17 (0.48–2.86)
Muslim
22
20
1
Completed educational level
Do not read and write
193
199
1.04 (0.66–1.63)
1.03 (0.54–1.97)
Read and write only
62
53
1.25 (0.72–2.16)
1.14 (0.55–2.36)
Primary school (grade 1–8)
45
45
1.08 (0.60–1.91)
0.71 (0.34–1.48)
Above secondary school (above grade 9)
45
48
1
Marital status
Married
237
243
1.09 (0.78–1.50)
0.79 (0.50–1.26)
Unmarried
108
102
1
Occupation
Farmers
215
215
0.77 (0.45–1.35)
0.57 (0.27–1.21)
Employed
49
52
1.08 (0.53–2.19)
0.96 (0.41–2.22)
Unemployed
39
30
0.82 (0.39–1.72)
0.61 (0.25–1.51)
Student
42
48
1
Gender of HH head
Female
293
297
0.91 (0.60–1.39)
0.76 (0.52–1.11)
Male
52
48
1
Area of residence
Rural
245
239
1.09 (0.78–1.51)
0.73 (0.44–1.21)
Urban
100
106
1
Duration of stay in the endemic area
<16 years
206
197
0.90 (0.66–1.22)
0.89 (0.60–1.34)
≥16 years
139
148
1
Thought of being susceptible to LF
No
63
39
1.75 (1.14–2.70)
2.36 (1.80–4.32)
Yes
282
306
1
Having adequate knowledge of LF
No
179
131
1.76 (1.42–3.77)
1.88 (1.38–3.81)
Yes
166
214
1
Having LLITNs
No
86
75
1.19 (0.84–1.70)
1.08 (0.75–1.58)
Yes
259
270
1
Use of LLITNs (n = 529)
No
42
22
2.18 (1.26–2.77)
2.13 (1.18–3.83)
Yes
217
248
1
Preferred mode of drug delivery
Home to home
180
169
1
Central
149
157
0.89 (0.65–1.21)
0.78 (0.58–1.38)
Health facility
16
19
1.01 (0.46–2.21)
0.92 (0.55–2.12)
Community distributors
2
6
0.31 (0.62–1.57)
0.25 (0.4–1.2)
Preferred drug dispenser
CDDs
153
187
1.49 (1.10–2.01)
1.06 (0.71–1.59)
Health professional
192
158
1
Fear of drug side effects
No
315
332
1
Yes
30
13
2.43 (1.21–4.80)
2.45 (1.23–4.86)
The perceived capacity of CDDs to distribute drugs
